On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.
D000818:Animals; D002118:Calcium / Q000097:blood / Q000502:physiology; D003404:Creatinine / Q000652:urine; D004032:Diet; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D005919:Glomerular Filtration Rate; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000150:complications*; D007684:Kidney Tubules / Q000378:metabolism; D008274:Magnesium / Q000097:blood; D009399:Nephrons / Q000503:physiopathology; D010280:Parathyroid Glands / Q000187:drug effects; D010281:Parathyroid Hormone / Q000097:blood / Q000378:metabolism; D010710:Phosphates / Q000652:urine; D010758:Phosphorus / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D011863:Radioimmunoassay
D010281:Parathyroid Hormone; D010710:Phosphates; D010758:Phosphorus; D003404:Creatinine; D008274:Magnesium; D002118:Calcium